Differential Levels and Biological Roles of eNOS and SCUBE1 in Endothelial Dysfunction: A Systematic Review
DOI:
10.29303/jbt.v25i4.10226Published:
2025-10-13Downloads
Abstract
Endothelial dysfunction (ED) is a systemic disorder marked by impaired nitric oxide (NO) availability, which is essential for maintaining vascular tone and managing oxidative stress. This dysfunction contributes to vascular pathologies such as atherosclerosis and coronary artery disease (CAD) by fostering vasoconstriction, increased permeability, and inflammatory responses, thereby highlighting the urgent need for biomarkers and interventions aimed at mitigating endothelial dysfunction and its associated risks. The relationship between eNOS and SCUBE1 relates to endothelial function and oxidative stress. This study seeks to clarify the benefits and drawbacks of each biomarker in its capacity as a preventive strategy against endothelial dysfunction. This systematic review, adhering to the PRISMA Checklist, examines evidence on the role of endothelial function and oxidative stress in endothelial dysfunction, with emphasis on the biomarkers eNOS and SCUBE1. Literature searches were conducted in PubMed, ScienceDirect, and Google Scholar, and study quality was appraised based on reported biomarker values and relevance. There were 8 articles with increased eNOS and decreased ROS in several treatments, associated with prevention of endothelial dysfunction. There were 6 articles with increased SCUBE1 in several diseases (breast cancer, STEMI, hashimoto's thyroiditis, peripheral ischemic, pulmonary arterial hypertension, atherosclerosis) being markers of endothelial dysfunction. Both biomarkers can work well according to their release pathways, they can be novel biomarkers of endothelial dysfunction in various diseases. Their main role is on endothelial function, SCUBE1 controls BMPR2 signaling (angiogenic, proliferation, apoptosis) and eNOS focuses on endothelial health through NO production (vasodilation, maintaining vascular tone).
Keywords:
Biomarker, endothelial dysfunction, nitric oxide, platelet.References
Akdoğan, E., Ayaz, T., Kırbaş, A., & Rakıcı, H. (2019). Is SCUBE1 helpful to predict the arterial thrombotic risk in patients with multi-ple myeloma: a preliminary study. Hippokratia, 23(1), 21–24. doi: 10.1016/0002-9378(82)90258-7
Ali, H. (2024). SCUBE in human diseases: A systematic review. Marmara Medical Journal, 37(2), 106–114. doi: 10.5472/marumj.1484448
Ayvaz Çelik, H. H., Kuyumcu, M. S., Şirin, F. B., Cirit, M., Korkmaz, S., Erturan, İ., Çelik, S., & Yıldırım, M. (2023). Could SCUBE-1 be a marker for subclinical atherosclerosis other than carotid artery intima-media thickness in doi: 10.1016/j.abd.2022.08.012
Bilir, B., Soysal-Atile, N., Bilir, B., Yilmaz, I., Bali, I., Altintas, N., Baykiz, D., Aydin, M., & Guldiken, S. (2016). Evaluation of SCUBE-1 and sCD40L biomarkers in patients with hypothyroidism due to Hashimoto’s thyroiditis: A single-blind, controlled clinical study. European Review for Medical and Pharmacological Sciences, 20(3), 407–413. PMID: 26914113
Bockus, L., & Kim, F. (2022). Coronary endothelial dysfunction: from pathogenesis to clinical implications. Open Heart, 9(2). doi: 10.1136/openhrt-2022-002200
Bolayır, H. A., Güneş, H., Kıvrak, T., Şahin, Ö., Akaslan, D., Kurt, R., Bolayır, A., & İmadoğlu, O. (2017). The role of scube1 in the pathogenesis of no-reflow phenomenon presenting with st segment elevation myocardial infarction. Anatolian Journal of Cardiology, 18(2), 122–127. doi: 10.14744/AnatolJCardiol.2017.7705
Chakraborty, S., & Ain, R. (2017). Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling. Journal of Biological Chemistry, 292(16), 6600–6620. doi: 10.1074/jbc.M116.742627
Daiber, A., Xia, N., Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Münzel, T., & Li, H. (2019). New Therapeutic Implications of Endothelial Nitric Oxide Synthase (eNOS) Function/Dysfunction in Cardiovascular Disease. International Journal of Molecular Sciences, 20(1), 187. doi: 10.3390/ijms20010187
Fredette, N. C., Malik, E., Mukhtar, M. L., Prossnitz, E. R., & Terada, N. (2020). A hypertension patient-derived iPSC model demonstrates a role for G protein-coupled estrogen receptor in hypertension risk and development. American Journal of Physiology - Cell Physiology, 319(5), C825–C838. doi: 10.1152/ajpcell.00350.2019
Higashi, Y. (2022). Roles of Oxidative Stress and Inflammation in Vascular Endothelial Dysfunction-Related Disease. Antioxidants, 11(10). doi: 10.3390/antiox11101958
Janaszak-Jasiecka, A., Płoska, A., Wierońska, J. M., Dobrucki, L. W., & Kalinowski, L. (2023). Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets. Cellular & Molecular Biology Letters, 28(1), 21. doi: 10.1186/s11658-023-00423-2
Kok, M., Aslankoc, R., Ozmen, O., Dora, D., & Ellidag, H. Y. (2023). SCUBE-1 in the Diagnosis and Follow-up Of Subclinical Atherosclerosis in the Experimental Diabetes Mellitus and Obesity Model. BioRxiv, 10(03), 560790. doi: 10.1101/2023.10.03.560790
Lamas, A. Z., Caliman, I. F., Dalpiaz, P. L. M., de Melo, A. F., Abreu, G. R., Lemos, E. M., Gouvea, S. A., Bissoli, N. S., Zandonadi, A., Facco, I., Lima, P., Dalpiaz, M., Ferreira, A., Jr, D. M., Rodrigues, G., Moreira, E., Lamas, A. Z., Caliman, I. F., Dalpiaz, P. L. M., … Bissoli, N. S. (2015). Comparative effects of estrogen, raloxifene and tamoxifen on endothelial dysfunction, inflammatory markers and oxidative stress in ovariectomized rats. Life Sciences, 124, 101–109. doi: 10.1016/j.lfs.2015.01.004
Li, Q., Ouyang, X., & Lin, J. (2022). The impact of periodontitis on vascular endothelial dysfunction. Frontiers in Cellular and Infection Microbiology, 12(September), 1–11. doi: 10.3389/fcimb.2022.998313
Li, Q., Yon, J., Cai, H., Angeles, C. L., & Angeles, L. (2016). Mechanisms and Consequences of eNOS Dysfunction in Hypertension. Journal of Hypertension, 33(6), 1128–1136. doi: 10.1097/HJH.0000000000000587.
Lin, Y. C., Sahoo, B. K., Gau, S. S., & Yang, R. B. (2023). The biology of SCUBE. Journal of Biomedical Science, 30(1), 1–45. doi: 10.1186/s12929-023-00925-3
Łuczak, A., Madej, M., Kasprzyk, A., & Doroszko, A. (2020). Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases. Oxidative Medicine and Cellular Longevity, 2020. doi: 10.1155/2020/1417981
Nguyen, T. D., Rahman, N. T., Sessa, W. C., & Lee, M. Y. (2023). Endothelial nitric oxide synthase (eNOS) S1176 phosphorylation status governs atherosclerotic lesion formation. Frontiers in Cardiovascular Medicine, 10(November). doi: 10.3389/fcvm.2023.1279868
Page, M. J., Mckenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-wilson, E., Mcdonald, S., … Moher, D. (2021). The PRISMA 2020 statement : an updated guideline for reporting systematic reviews Systematic reviews and Meta-Analyses. doi: 10.1136/bmj.n71
Penna, C., & Pagliaro, P. (2025). Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases. Antioxidants, 14(3), 1–30. doi: 10.3390/antiox14030256
Roy, R., Wilcox, J., Webb, A. J., & O’Gallagher, K. (2023). Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences, 24(20), 15200. doi: 10.3390/ijms242015200
Shaito, A., Aramouni, K., Assaf, R., Parenti, A., Orekhov, A., Yazbi, A. El, Pintus, G., & Eid, A. H. (2022). Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases. Frontiers in Bioscience - Landmark, 27(3). doi: 10.31083/j.fbl2703105
Sharma, A., Sellers, S., Stefanovic, N., Leung, C., Tan, S. M., Huet, O., Granville, D. J., Cooper, M. E., De Haan, J. B., & Bernatchez, P. (2015). Direct endothelial nitric oxide synthase activation provides atheroprotection in diabetes-accelerated atherosclerosis. Diabetes, 64(11), 3937–3950. doi: 10.2337/db15-0472
Sogut, O., Sönmez, E., Yigit, M., Turkdogan, K. A., Kucukdaglı, O. T., Yigit, E., Ozer, O. F., & Civelek, C. (2017). The predictive value of signal peptide-CUB-EGF domain-containing protein1 (SCUBE1) in terms of the duration of peripheral ischemia and exposure to reperfusion. Biomedical Research (India), 28(2), 492–494.
Stamm, P., Oelze, M., Steven, S., Kr, S., Kvandova, M., Kalinovic, S., Jasztal, A., Kij, A., Kuntic, M., Teresa, M., Jimenez, B., Proniewski, B., Li, H., Schulz, E., Chlopicki, S., Daiber, A., Münzel, T., Kröller-Schön, S., Kvandova, M., … Münzel, T. (2021). Direct comparison of inorganic nitrite and nitrate on vascular dysfunction and oxidative damage in experimental arterial hypertension. Nitric Oxide, 113–114(December 2020), 57–69. doi: 10.1016/j.niox.2021.06.001
Sun, W., Tang, Y., Tai, Y. Y., Handen, A., Zhao, J., Speyer, G., Al Aaraj, Y., Watson, A., Romanelli, M. E., Sembrat, J., Rojas, M., Simon, M. A., Zhang, Y., Lee, J., Xiong, Z., Dutta, P., Vasamsetti, S. B., McNamara, D., McVerry, B., … Chan, S. Y. (2020). SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension. JACC: Basic to Translational Science, 5(11), 1073–1092. doi: 10.1016/j.jacbts.2020.08.010
Takahashi, N., Shibata, R., Ouchi, N., Sugimoto, M., Murohara, T., & Komori, K. (2015). Metformin stimulates ischemia-induced revascularization through an eNOS dependent pathway in the ischemic hindlimb mice model. Journal of Vascular Surgery, 61(2), 489–496. doi: 10.1016/j.jvs.2013.09.061
Topcu, T. O., Kavgaci, H., Ozdemir, F., Aksoy, A., Erdem, D., Mentese, A., Yaman, H., Tufan, G., Orem, A., & Aydin, F. (2015). Elevated serum levels of SCUBE1, a marker for coagulation, in patients with breast cancer. Tohoku Journal of Experimental Medicine, 237(2), 127–132. doi: 10.1620/tjem.237.127
Tran, N., Garcia, T., Aniqa, M., Ali, S., Ally, A., & Nauli, S. M. (2022). Endothelial Nitric Oxide Synthase (eNOS) and the Cardiovascular System: in Physiology and in Disease States. HHS Public Access, 15(2), 153–177. PMID: 35072089 PMCID: PMC8774925
Xu, L., Xu, C., Lin, X., Lu, H., & Cai, Y. (2021). Interference with lysophosphatidic acid receptor 5 ameliorates oxidized low-density lipoprotein-induced human umbilical vein endothelial cell injury by inactivating NOD-like receptor family, pyrin domain containing 3 inflammasome signaling. Bioengineered, 12(1), 8089–8099. doi: 10.1080/21655979.2021.1983975
Xu, S., Ha, C. H., Wang, W., Xu, X., Yin, M., Jin, F. Q., Mastrangelo, M., Koroleva, M., Fujiwara, K., & Jin, Z. G. (2017). PECAM1 regulates flow-mediated Gab1 tyrosine phosphorylation and signaling. Physiology & Behavior, 176(12), 139–148. doi: 10.1016/j.cellsig.2015.12.007.PECAM1
Zhan, B., Xu, Z., Zhang, Y., Wan, K., Deng, H., Wang, D., Bao, H., Wu, Q., Hu, X., Wang, H., Huang, X., & Cheng, X. (2020). Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K/Akt/eNOS pathway. Biomedicine and Pharmacotherapy, 127(March), 110121. doi: 10.1016/j.biopha.2020.110121
License
Copyright (c) 2025 Muhammad Abi Ghoffari Siregar, Hirowati Ali, Rizki Rahmadian, Salsabila Faiha Wiendra Rasya
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
